Amid Stronger Than Expected Retail Performance, CVS Health Boosts 2021 Guidance

CVS Health Corp CVS boosted its 2021 guidance ahead of its fourth-quarter earnings in early February, with executives citing better-than-expected performance in its retail segment.

  • In an SEC filing, the Company raised its full-year earnings projections to $8.33 - $8.38 per share from a previous estimate of $8
  • The Company also affirmed its 2022 guidance of $8.10 - $8.30 per share.
  • RelatedCVS Plans 900 Store Closures Over Three Years.
  • During the annual J.P. Morgan Healthcare Conference, CVS's chief financial officer, Shawn Guertin, said the retail business's strong results in the fourth quarter account for about 80% of the overperformance CVS saw.
  • See the Company presentation here.
  • As COVID-19 pandemic response, the Company administered around 59 million vaccines and about 32 million tests.
  • Price Action: CVS shares are up 0.85% at $105.95 during the market session on the last check Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceHealth CareGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!